Phase 1 Trial of a Therapeutic Anti–Yellow Fever Virus Human Antibody

Phase 1 Trial of a Therapeutic Anti–Yellow Fever Virus Human Antibody

Show other versions (1)

Copyright © 2020 Massachusetts Medical Society. BACKGROUND Insufficient vaccine doses and the lack of therapeutic agents for yellow fever put global health at risk, should this virus emerge from sub-Saharan Africa and South America. METHODS In phase 1a of this clinical trial, we assessed the safety,...

Full description

Bibliographic Details
Main Authors: Low, Jenny G, Ng, Justin HJ, Ong, Eugenia Z, Kalimuddin, Shirin, Wijaya, Limin, Chan, Yvonne FZ, Ng, Dorothy HL, Tan, Hwee-Cheng, Baglody, Anjali, Chionh, Yok-Hian, Lee, Debbie CP, Budigi, Yadunanda, Sasisekharan, Ram, Ooi, Eng-Eong
Other Authors: Singapore-MIT Alliance in Research and Technology (SMART)
Format: Article
Language:English
Published: Massachusetts Medical Society 2022
Online Access:https://hdl.handle.net/1721.1/133594.2

Internet

https://hdl.handle.net/1721.1/133594.2

Similar Items